These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 25769723)
1. The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a cxcl signaling module. Chen K; Wu K; Jiao X; Wang L; Ju X; Wang M; Di Sante G; Xu S; Wang Q; Li K; Sun X; Xu C; Li Z; Casimiro MC; Ertel A; Addya S; McCue PA; Lisanti MP; Wang C; Davis RJ; Mardon G; Pestell RG Cancer Res; 2015 May; 75(10):1992-2004. PubMed ID: 25769723 [TBL] [Abstract][Full Text] [Related]
2. DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling. Liu Y; Zhou R; Yuan X; Han N; Zhou S; Xu H; Guo M; Yu S; Zhang C; Yin T; Wu K Oncotarget; 2015 Apr; 6(11):8621-34. PubMed ID: 25940701 [TBL] [Abstract][Full Text] [Related]
3. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. Wu K; Li A; Rao M; Liu M; Dailey V; Yang Y; Di Vizio D; Wang C; Lisanti MP; Sauter G; Russell RG; Cvekl A; Pestell RG Mol Cell Biol; 2006 Oct; 26(19):7116-29. PubMed ID: 16980615 [TBL] [Abstract][Full Text] [Related]
4. Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8. Wu K; Katiyar S; Li A; Liu M; Ju X; Popov VM; Jiao X; Lisanti MP; Casola A; Pestell RG Proc Natl Acad Sci U S A; 2008 May; 105(19):6924-9. PubMed ID: 18467491 [TBL] [Abstract][Full Text] [Related]
5. Suppression of DACH1 promotes migration and invasion of colorectal cancer via activating TGF-β-mediated epithelial-mesenchymal transition. Wang P Biochem Biophys Res Commun; 2015 May; 460(2):314-9. PubMed ID: 25778865 [TBL] [Abstract][Full Text] [Related]
6. Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer. Chen K; Wu K; Gormley M; Ertel A; Wang J; Zhang W; Zhou J; Disante G; Li Z; Rui H; Quong AA; McMahon SB; Deng H; Lisanti MP; Wang C; Pestell RG Oncotarget; 2013 Jun; 4(6):923-35. PubMed ID: 23798621 [TBL] [Abstract][Full Text] [Related]
7. PRH/HHex inhibits the migration of breast and prostate epithelial cells through direct transcriptional regulation of Endoglin. Kershaw RM; Siddiqui YH; Roberts D; Jayaraman PS; Gaston K Oncogene; 2014 Dec; 33(49):5592-600. PubMed ID: 24240683 [TBL] [Abstract][Full Text] [Related]
8. The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses. Li Z; Jiao X; Robertson AG; Di Sante G; Ashton AW; DiRocco A; Wang M; Zhao J; Addya S; Wang C; McCue PA; South AP; Cordon-Cardo C; Liu R; Patel K; Hamid R; Parmar J; DuHadaway JB; Jones SJM; Casimiro MC; Schultz N; Kossenkov A; Phoon LY; Chen H; Lan L; Sun Y; Iczkowski KA; Rui H; Pestell RG Oncogene; 2023 Jun; 42(22):1857-1873. PubMed ID: 37095257 [TBL] [Abstract][Full Text] [Related]
10. The type 1 insulin-like growth factor receptor and resistance to DACH1. DeAngelis T; Wu K; Pestell R; Baserga R Cell Cycle; 2011 Jun; 10(12):1956-9. PubMed ID: 21558809 [TBL] [Abstract][Full Text] [Related]
11. Pigment epithelial-derived factor and melanoma differentiation associated gene-7 cytokine gene therapies delivered by adipose-derived stromal/mesenchymal stem cells are effective in reducing prostate cancer cell growth. Zolochevska O; Yu G; Gimble JM; Figueiredo ML Stem Cells Dev; 2012 May; 21(7):1112-23. PubMed ID: 21671747 [TBL] [Abstract][Full Text] [Related]
12. DACH1 regulates cell cycle progression of myeloid cells through the control of cyclin D, Cdk 4/6 and p21Cip1. Lee JW; Kim HS; Kim S; Hwang J; Kim YH; Lim GY; Sohn WJ; Yoon SR; Kim JY; Park TS; Park KM; Ryoo ZY; Lee S Biochem Biophys Res Commun; 2012 Mar; 420(1):91-5. PubMed ID: 22405764 [TBL] [Abstract][Full Text] [Related]
13. Early Growth Response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer. Baron VT; Pio R; Jia Z; Mercola D Br J Cancer; 2015 Feb; 112(4):755-64. PubMed ID: 25633035 [TBL] [Abstract][Full Text] [Related]
14. The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Bauskin AR; Brown DA; Junankar S; Rasiah KK; Eggleton S; Hunter M; Liu T; Smith D; Kuffner T; Pankhurst GJ; Johnen H; Russell PJ; Barret W; Stricker PD; Grygiel JJ; Kench JG; Henshall SM; Sutherland RL; Breit SN Cancer Res; 2005 Mar; 65(6):2330-6. PubMed ID: 15781647 [TBL] [Abstract][Full Text] [Related]
15. MiR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression. Li F; Gu C; Tian F; Jia Z; Meng Z; Ding Y; Yang J Oncol Rep; 2016 May; 35(5):2859-65. PubMed ID: 26986507 [TBL] [Abstract][Full Text] [Related]
16. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer. Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945 [TBL] [Abstract][Full Text] [Related]
17. ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype. Smith AM; Findlay VJ; Bandurraga SG; Kistner-Griffin E; Spruill LS; Liu A; Golshayan AR; Turner DP Carcinogenesis; 2012 Mar; 33(3):572-80. PubMed ID: 22232738 [TBL] [Abstract][Full Text] [Related]
18. PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFκB and PPARγ. Hirsch J; Johnson CL; Nelius T; Kennedy R; Riese Wd; Filleur S Cytokine; 2011 Aug; 55(2):202-10. PubMed ID: 21570865 [TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1. Peng Y; Shi J; Du X; Wang L; Klocker H; Mo L; Mo Z; Zhang J Int J Biochem Cell Biol; 2013 Mar; 45(3):521-30. PubMed ID: 23246486 [TBL] [Abstract][Full Text] [Related]
20. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells. Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]